The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MONARCH 3: A randomized phase III study of anastrozole or letrozole plus abemaciclib, a CDK4/6 inhibitor, or placebo in first-line treatment of women with HR+, HER2-locoregionally recurrent or metastatic breast cancer (MBC).
 
Matthew P. Goetz
Consulting or Advisory Role - Lilly (Inst)
Travel, Accommodations, Expenses - Lilly
 
Masakazu Toi
No Relationships to Disclose
 
Suzanne Klise
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Travel, Accommodations, Expenses - Lilly
 
Martin Frenzel
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Nawel Bourayou
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Honoraria - Lilly
 
Angelo Di Leo
Honoraria - AstraZeneca; Eisai; Genomic Health; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Novartis; Pfizer; Roche